CHICAGO (Reuters) - Consumer Reports, the 76-year-original publication best known for its reviews of automobiles and refrigerators, is afflictive to galvanize the American public into protesting the path medical devices are approved by the U.S. Food and put ~s into Administration.

The past couple of years get seen a steady drumbeat of concerns ~ means of some lawmakers that health regulators are doing also little to protect consumers from hastily approved devices that can cause injury or even death.

It's a incubus scenario," Consumer Reports President Jim Guest wrote in one email blast to 1 million Americans earlier this year. “The instil that fixed your knee or your purpose may actually be a ticking time bomb that could cripple or kill you.

This isn't knowledge of principles fiction. Millions of medical devices including counterfeited hips, contact lens solution, heart stents, and pacemakers are inner reality recalled -- 700 different products a year. And the monstrous majority of recalled products were not at any time safety tested in humans, because the manufacturers claimed they were 'like' to products already on the mart," he wrote.

For decades, certain devices be obliged been cleared by the FDA independently of the manufacturers ever having to discriminative characteristic them in human beings in clinical trials, that take time and money.

The extravagant-track approval process is known in the industrial art as Pre-market Notification, or 510(k), named beneficial to the numbered section of the Food, drug and Cosmetic Act.

Intended for cast down- and moderate-risk medical devices, similar as blood pressure cuffs and hypodermic needles, likewise many high-risk devices, such for the re~on that hip implants and heart valves, were cleared end the 510(k) process and later ground to cause life-threatening incidents, according to Guest.

Consumer Reports, some independent nonprofit, publishes a monthly repository, as well as newsletters focusing in successi~ health, money, travel, home and garden, weddings and other topics.

It has a lump of 8 million subscribers to total of its publications and 800,000 as antidote to its On Health monthly newsletter, what one. was established in 1989. On Health maintains its own medical experts, but sometimes taps externality physicians.

Consumer Reports' advocacy arm, Consumers Union, would not betray how much money it is spending on efforts to change the curative device approval process, but says its campaign is a surpass priority. The campaign was launched far advanced last year at its annual Patient Safety Summit.

The Institute of Medicine, a nongovernmental, nonprofit making that provides medical advice to acumen makers and the public, characterized the 510(k) approval projection as “fatally flawed" and said it should have existence scrapped.

The FDA, for its apportionment, believes that the current device-approval series of measures could stand some improvement. Dr. Jeffrey Shuren, manager of FDA's Center for Devices and Radiological Health, related 510(k) should not be eliminated, nevertheless thought changes to the process were in regularity.

Lawmakers have the authority to vary the way devices are approved. FDA cannot vary the process, but it can make different the way it classifies devices. Hip implants and affections valves, for example, are categorized being of the cl~s who “moderate risk," which allows them to be of use through the 510(k) process.

The therapeutical device industry has argued for both leaving the 510(k) process being of the kind which it is or further streamlining the approval procedure. Most new medical devices -- about 4,000 in 2009 -- are cleared through the accelerated program.

AdvaMed, the manual occupation group representing medical device makers, warns that additional regulation would stifle innovation and that streamlining the step is necessary to move the abundant volume of products awaiting approval end the system.

HIGH-PROFILE CASE

In one of the highest-profile cases, Johnson & Johnson in August 2010 recalled its ASR hip implants after they failed at a higher-than-expected cost, with some patients experiencing pain, joint dislocation and sometimes systemic damage to the central powerful system, thyroid and heart. Many patients esteem cobalt and chromium poisoning from the implant.

Surgical mesh -- used to repair or reinforce gently tissue where there is weakness, for such procedures as pelvic organ prolapses -- has furthermore been a subject of major recalls, including products ~ the agency of Boston Scientific Corp and J&J. Almost every synthetic mesh device on the mart today cleared through the 510(k) performance was based on the ProteGen mesh, manufactured by Boston Scientific, even granting it was recalled in 1999.

Jaye Nevarez, of Lakewood, Colorado, uttered she never would have had J&J's Gynecare surgical entangle implanted in her body four years ~ne had she known how easy it was in favor of products to gain approval and in what plight severe the complications could be.

At verge of life 50, Nevarez cannot walk because of force damage that she believes is a chain of cause and effect of mesh erosion.

I'm with keen perceptions. I function, but I don't employment well. I'm in pain each day, all day long, day ~wards day, and it doesn't spree away. It's not worth it," declared Nevarez, who is suing J&J.

A J&J prolocutor declined to comment.

BASIS FOR REJECTION

Possible changes to sanatory device regulations are especially relevant this year, in the same manner with Congress is reviewing the fees the diligence pays to the FDA in reciprocity for speedier review times. Since fees from makers of drugs and healing devices provide more than a third part of the FDA's funding, the broadside often serves as a vehicle in opposition to broader FDA-related changes.

Last month, U.S. congressmen Edward Markey (D-Massachusetts), Henry Waxman (D-California) and Jan Schakowsky (D-Illinois), introduced legislation -- the Safety Of Untested and New Devices Act of 2012, dubbed SOUND Devices Act -- that would give the FDA more authority to renounce a manufacturer's application for a fresh device if it was based attached a similar product that was recalled.

Guest afore~ any new law should also ask rigorous testing of the devices upfront and a public registry that would track device exploit over time. Raising manufacturers' user fees that supply FDA could help fund a registry, he said.

Some 93,000 people have been implanted through DePuy's ASR hip system worldwide and J&J faces added than 2,000 lawsuits in dignity and federal court.

When clients invitation, they are livid when they perceive out how (the device) was approved. They maxim 'I don't understand how this was skilful to get on the market in the earliest place,'" said attorney Felecia Stern of Bernstein Liebhard LLP, a New York regulation firm handling more than 200 cases off J&J over the ASR haunch. However, these patients, she said, are usually over overwhelmed by medical problems to procure involved in activism.

Carol Kochhar-Bryant, a 62-year-thoughtful professor and senior associate dean at the Graduate School of Education and Human Development at George Washington University, was one recipient of the Consumer Reports' email blast.

She had the ASR implanted in 2009. The commissure failed after a couple of years and she declared it left her with high chromium and cobalt levels in her bloodstream, a class known as metallosis that some experts concern could cause cancer and other great problems. She continued to have agony and recently underwent a second, else extensive surgery to scrape out metal shavings embedded in the surrounding tissues of her hip and replace the entire ball and socket by a new device.

I was proud there was a much more strict process," she said, referring to the approval projection of her hip replacement. “I did not quiz my doctors on how these things draw near to the market. They gave me a division of pamphlets on it. I went back to appear to see what adverse events were listed, on the contrary there's nothing in there."

Katie Ayers, 42, furthermore had the ASR hip implanted whenever she was 36 years old. Blood tests revealed that she likewise had elevated levels of cobalt and chromium, and she clear to have the device replaced through a J&J ceramic implant.

Ayers is suing J&J and testified prior to Congress last year. Kochhar-Bryant said she has not yet decided on legal action.

TWO STUDIES, DIFFERENT CONCLUSIONS

AdvaMed cites a September 2010 study ~ means of Battalle, a research organization it commissioned to anticipate at the issue, that found that Class 1 recalls, the greatest in number serious kind, accounted for only 77 public of 46,690 (0.16 percent) of the therapeutical devices -- including low risk devices -- that were cleared end the 510(k) process between January 1, 2005 and May 1, 2010.

But a greater degree recent study of the same given conditions had a far different result. The study by Diana Zuckerman and Paul Brown of the National Research Center for Women and Families, and Dr. Steven Nissen, the great-profile cardiovascular medicine chair at Cleveland Clinic, was published in the lord-reviewed medical journal, Archives of Internal Medicine, in February 2011.

Zuckerman before-mentioned Battalle understates the problem because sundry products are often recalled after they be in possession of been on the market for five years or in addition. In addition, she noted that the Battalle study without more looked at raw numbers of wile approvals and did not consider for what cause many people were affected by recalls.

If you care here and there public health, you look at to what degree many devices were recalled and how many lives were put at jeopardize," said Zuckerman.

She said her study concluded that additional than 70 percent of the verging on taint-risk recalls were for medical devices that the FDA categorized like moderate risk" and therefore went end the 510(k) process for approval.

AdvaMed, notwithstanding, said the real problem at FDA is growing delays and inconsistency in product reviews. AdvaMed Senior Vice President David Nexon before-mentioned consumer groups often do not gain a realistic understanding of risk.

Consumer groups, what one. typically represent primarily people who are healthy, often have a very heavy significance on avoiding any risks," Nexon declared.

Patient groups ... have an equally spicy interest in the development of of recent origin treatment and cures, and they be informed that there is always a residue between risk and benefit," he added.

@yahoonews up~ Twitter, become a fan on Facebook